483
Steri-Med Pharma Inc.FDA 483 - Steri-Med Pharma Inc. - February 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Steri-Med Pharma Inc., a sterile manufacturer in Upton, revealed significant deficiencies in aseptic processing areas. The firm's airflow visualization studies for its aseptic filling line were inadequate, showing turbulent and eddying smoke patterns. Additionally, there was a lack of proper studies and monitoring to ensure a storage cart did not disrupt airflow in critical Grade A and B areas.
Open in Dashboard
ID · eb8cc7a6-9f52-4ee2-80f2-6ccad5913047